This inventor holds 3 USPTO granted patents. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2004-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Somerville, MA (US) (2004)
- Belmont, MA (US) (2005 - 2011)
Company Filing History:
Years Active: 2004-2011
Title: The Innovative Contributions of Vladimir N Malashkevich
Introduction
Vladimir N Malashkevich is a prominent inventor based in Somerville, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of HIV treatment. With a total of 3 patents to his name, Malashkevich's work is recognized for its potential impact on public health.
Latest Patents
Among his latest patents, Malashkevich has developed inhibitors of HIV membrane fusion. These patents include a method for identifying drugs or agents that inhibit the binding of the N-helix coiled-coil and the C helix of the HIV gp41 envelope protein. This innovative approach aims to provide new avenues for HIV treatment and prevention.
Career Highlights
Malashkevich is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His work has been instrumental in advancing our understanding of HIV and developing potential therapeutic strategies. His dedication to biomedical research has positioned him as a key figure in the fight against HIV.
Collaborations
Some of his notable coworkers include Debra Muir Eckert and David C Chan. Their collaborative efforts contribute to the innovative research environment at the Whitehead Institute.
Conclusion
Vladimir N Malashkevich's contributions to HIV research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
